User profiles for Michael Dreher
 | Michael DreherVerified email at ukaachen.de Cited by 6676 |
[HTML][HTML] The characteristics of 50 hospitalized COVID-19 patients with and without ARDS
M Dreher, A Kersten, J Bickenbach… - Deutsches Ärzteblatt …, 2020 - ncbi.nlm.nih.gov
Background The type of pneumonia (coronavirus disease 2019, COVID-19) that is caused
by the new coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) is …
by the new coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) is …
Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline
…, GJ Criner, GC Donaldson, M Dreher… - American journal of …, 2020 - atsjournals.org
Background: This document provides clinical recommendations for the pharmacologic treatment
of chronic obstructive pulmonary disease (COPD). It represents a collaborative effort on …
of chronic obstructive pulmonary disease (COPD). It represents a collaborative effort on …
[HTML][HTML] Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae
…, N Marx, D Müller-Wieland, B Hartmann, M Dreher… - Respiratory …, 2020 - Elsevier
Background Since December 2019 the novel coronavirus disease 2019 (COVID-19) has
been burdening all health systems worldwide. However, pulmonary and extrapulmonary …
been burdening all health systems worldwide. However, pulmonary and extrapulmonary …
High-intensity versus low-intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trial
M Dreher, JH Storre, C Schmoor, W Windisch - Thorax, 2010 - thorax.bmj.com
Rationale The conventional approach of low-intensity non-invasive positive pressure ventilation
(NPPV) produces only minimal physiological and clinical benefits in patients with stable …
(NPPV) produces only minimal physiological and clinical benefits in patients with stable …
Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit
A Krüttgen, CG Cornelissen, M Dreher… - Journal of virological …, 2021 - Elsevier
There is an ongoing need for reliable antigen assays for timely and easy detection of
individuals with acute SARS-CoV-2 infection. Using 75 swabs from patients previously tested …
individuals with acute SARS-CoV-2 infection. Using 75 swabs from patients previously tested …
Average volume-assured pressure support in obesity hypoventilation: a randomized crossover trial
JH Storre, B Seuthe, R Fiechter, S Milioglou, M Dreher… - Chest, 2006 - Elsevier
Background Average volume-assured pressure support (AVAPS) has been introduced as a
new additional mode for a bilevel pressure ventilation (BPV) device (BiPAP; Respironics; …
new additional mode for a bilevel pressure ventilation (BPV) device (BiPAP; Respironics; …
Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
A Krüttgen, CG Cornelissen, M Dreher, M Hornef… - Journal of clinical …, 2020 - Elsevier
Background Facing the ongoing pandemic caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), there is an urgent need for serological assays identifying …
coronavirus 2 (SARS-CoV-2), there is an urgent need for serological assays identifying …
Outcome of patients with stable COPD receiving controlled noninvasive positive pressure ventilation aimed at a maximal reduction of PaCO2
W Windisch, S Kostić, M Dreher, JC Virchow Jr… - Chest, 2005 - Elsevier
Study objectives The role of noninvasive positive pressure ventilation (NPPV) has been well
established in the treatment of acute hypercapnic respiratory failure due to COPD. However, …
established in the treatment of acute hypercapnic respiratory failure due to COPD. However, …
Long COVID‐19: Objectifying most self‐reported neurological symptoms
…, MI Rust, U Ermis, M Dreher… - Annals of clinical …, 2022 - Wiley Online Library
Objectives We aimed to objectify and compare persisting self‐reported symptoms in initially
hospitalized and non‐hospitalized patients after infection with severe acute respiratory …
hospitalized and non‐hospitalized patients after infection with severe acute respiratory …
[HTML][HTML] ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19
Objectives The RNA virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is responsible for coronavirus disease 2019 (COVID-19). Cell entry is mediated by the …
is responsible for coronavirus disease 2019 (COVID-19). Cell entry is mediated by the …